CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
Clinical trial NCT01583686 · TERMINATED
Trial details
- NCT number
- NCT01583686
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-04
- Primary completion
- 2018-12-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.